Merck (MRK) Treasury Shares (2009 - 2026)

Merck (MRK) reported Treasury Shares of $63.7 billion for Q1 2026, up 7.32% year-over-year from $59.4 billion in Q1 2025, and up 1.19% quarter-over-quarter from $63.0 billion in Q4 2025.

Merck (MRK) Treasury Shares (2009 - 2026) Analysis & Trends

Merck (MRK) has 18 years of Treasury Shares data on file, last reported at $63.7 billion in Q1 2026.

  • Treasury Shares for Q1 2026 came in at $63.7 billion, up 7.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $63.7 billion (up 7.32% YoY), and the FY2025 annual result was $63.0 billion, up 8.05% from the prior year.
  • Treasury Shares rose to $63.7 billion in Q1 2026 per MRK's latest filing, from $63.0 billion in the prior quarter.
  • Over five years, Treasury Shares peaked at $1.1 billion in Q1 2026 and troughed at $4.0 million in Q3 2023.
  • A 5-year average of $872.4 million and a median of $1.0 billion in 2022 frame the typical range for Treasury Shares.
  • The sharpest annual moves came in 2022 and 2025: Treasury Shares slipped 1.09% in 2022, then grew 8.05% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $56.5 billion in 2022, then gained by 1.7% to $57.4 billion in 2023, then gained by 1.48% to $58.3 billion in 2024, then grew by 8.05% to $63.0 billion in 2025, then gained by 1.19% to $63.7 billion in 2026.
  • Business Quant data shows MRK's Treasury Shares at $63.7 billion in Q1 2026, $63.0 billion in Q4 2025, and $61.8 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn -
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 3.01 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 713.26 Mn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 77.08 Mn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 1.11 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn -
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn -
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 3.94 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 881.00 Mn
10 Novartis Ag 108.28 Bn 107.60 Bn - -47.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 63.75 Bn
Mar 31, 2026 1.11 Bn
Mar 31, 2026 63.75 Bn
Mar 31, 2026 1.11 Bn
Dec 31, 2025 63.00 Bn
Dec 31, 2025 1.10 Bn
Dec 31, 2025 63.00 Bn
Dec 31, 2025 1.10 Bn
Sep 30, 2025 1.09 Bn
Sep 30, 2025 61.80 Bn
Sep 30, 2025 61.80 Bn
Sep 30, 2025 1.09 Bn
Jun 30, 2025 60.50 Bn
Jun 30, 2025 1.07 Bn
Jun 30, 2025 1.07 Bn
Jun 30, 2025 60.50 Bn
Mar 31, 2025 13.00 Mn
Mar 31, 2025 59.40 Bn
Mar 31, 2025 59.40 Bn
Mar 31, 2025 13.00 Mn